Traded as SIX: BION, FWB: BBZA Website www.bbbiotech.ch Total equity 1.234 billion CHF (2012) | Industry Investments Headquarters Küsnacht, Switzerland Total assets 1.376 billion CHF (2012) Type Aktiengesellschaft | |
 | ||
Key people Erich Hunziker (Chairman) Products Investment in biotechnology companies Profit (CHF 367.8 million) (2012) Stock price BION (SWX) CHF 56.70 -0.85 (-1.48%)24 Feb, 5:31 PM GMT+1 - Disclaimer Founded 1993, Schaffhausen, Switzerland | ||
Maydorns meinung tesla daimler deutsche bank bb biotech medigene jinkosolar solaredge
BB Biotech AG (Bank am Bellevue) is a Swiss investment company in the field of biotechnology. Since 1993 it is listed on the SIX Swiss Exchange, since 1997 on the German TecDAX and since 2000 on the Italian Borsa Italiana.
Contents
- Maydorns meinung tesla daimler deutsche bank bb biotech medigene jinkosolar solaredge
- Dax linde basf bb biotech qsc 2015 juni 01
- References
At of March 31, 2015 the six largest holdings in the BB Biotech portfolio were (in order of value): a 10.7% stake in Celgene; 9.5% of Isis Pharmaceuticals; , 9.1% of Incyte, 7.3% of Gilead Sciences; 7.3% of Actelion; 4.6% of Agios Pharmaceuticals.
Dax linde basf bb biotech qsc 2015 juni 01
References
BB Biotech Wikipedia(Text) CC BY-SA